EBR EBR Systems, Inc.
Healthcare · Medical Devices
· website
· 135 employees
$0.26
52wk 0.23 – 1.47
Overall
37.1
Value
78.0
Growth
—
Health
48.1
Quality
0.0
Momentum
5.2
Dividend
—
Price
About EBR Systems, Inc.
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.
Price analytics
Returns
| 1 day | -7.1% |
| 1 week | 6.1% |
| 1 month | -7.1% |
| 3 months | -35.0% |
| 6 months | -60.6% |
| 1 year | -78.2% |
| 3 years | -66.7% |
Risk
| Volatility (1y ann.) | 69.8% |
| Beta vs ASX 200 | 1.25 |
| Sharpe (1y) | -1.89 |
| VaR 95% (1-day) | -6.8% |
| Max drawdown (1y) | -83.7% |
| Off 1-year high | -82.3% |
Technicals
| RSI(14) | 50 |
| vs 50DMA | -5.4% |
| vs 200DMA | -52.7% |
| Trend | Death cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
78.0
Trailing P/E
—
Forward P/E
100
PEG ratio
—
EV / EBITDA
100
Price / Book
83
Price / Sales
0
Growth
—
Revenue growth (1y)
—
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health
48.1
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
78
Debt / Equity
63
Quality (Profitability & Cash Flow)
0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income
—
No meaningful dividend — pillar excluded from the overall score.
Momentum
5.2
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
23
Position in 52-week range
2
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$195.87M
P/E (trailing)
—
P/E (forward)
-2.82
EPS (trailing)
-0.26
Dividend yield
—
Payout ratio
0.0%
Beta
0.52
EV / EBITDA
-2.97
Price / Book
2.03
ROE
-102.5%
Operating margin
-621.8%
Net margin
0.0%
Total cash
$85.94M
Total debt
$59.68M
Current ratio
2.12
Debt / Equity
0.87
Free cash flow
$-56.94M
Avg volume
2.57M
Latest annual results
(FY ending 31 Dec 2025)
- Revenue$1.62M
- Gross profit$490.00K
- Operating income-$46.09M
- Net income-$48.76M
- Diluted EPS-0.11
- Free cash flow-$56.88M
- Net debt$52.79M